DAVID GRANOVSKY

Posts Tagged ‘recover’

THE DOOR OPENS

In ALL ARTICLES, BEST OF THE BEST, BUSINESS OF STEM CELLS, CATCH UP!, SCIENCE & STEM CELLS, STEM CELLS IN THE NEWS, VICTORIES & SUCCESS STORIES on May 30, 2017 at 11:20 am

UPDATE: JUNE 13TH 

In the next step of what may become the most monumental piece of medical legislature,

THE GOVERNOR OF TEXAS SIGNED HB 810!

HB 810 will be effective on 9/1/17  

I express virtually no surprise what so ever that there has been no media coverage of this.*  The only piece of confirming data I can find is on the Texas Legislature site and in articles written by the tireless and noble Patient Warriors, around the world, who have been fighting for their lives and for this for years.

 

HB-810
[original article below]
………………………………………………………………
Around the world, stem cells have been used for therapeutic application for decades, treating incurable illnesses, recovering terminal patients and improving qualities of life of untold numbers.  In some form or another, Rafael Nadal got them…along with Peyton Manning, Jarvis Greene, Kobe Bryant and Dana White and hundreds or thousands of other athletes and weekend warriors but mostly outside the US because they weren’t available here.
Sadly, we in the US were…a little slow…to get the message. Foolishly allowing ourselves to get embroiled in the distracting political, financial and religious controversies; we have not been allowed to treat our sick and dying. Tragically, listening to the uninformed who said: “they are unproven!” despite thousands of studies and trials from around the world, the US stuck to our guns and enjoyed some of the worst medical care in the world.  I wrote this in 2010:
“We are in fact about 8 years behind most of the developed world in stem cell research. The WHO ranks our health system at 37th, our life expectancy is 30th in the world, infant mortality is 34th in the world and this is all with our Health Expenditures as a % of GDP being almost the highest in the world (we are ranked #2).”
Like many before and after him, Gov Perry made some in roads in 2012 but hit the wall of American “backward thinking.” https://repairstemcell.wordpress.com/2012/04/14/texas-oks-experimental-stem-cell-therapy-limits-questions/
Now, Texas, House Bill 810 amended the bill which was “relating to the provision of certain investigational stem cell treatments to patients with certain severe chronic diseases or terminal illnesses and regulating the possession, use, and transfer of adult stem cells; creating a criminal offense,” and passed the Senate, unanimously.
STEM CELLS FOR SCLERODERMA
This is the bill now:

The bill is on its way to the Governor’s office for signature. This has been a LONG time coming.

A hearty congratulations goes out especially to the tireless patient advocates/patient warriors who said: “no more!” and threw off the yoke of servitude to a medical system which no longer served their self-interests. Their efforts and those of many, many others have inexorably, infinitesimally, pushed the needle over time against multiple immovable objects.

What happens next?  There will be chaos, turmoil and scrambling.  There will be resistance and bad mouthing and nay saying…and in the end, Texas industry will likely generate billions in revenue, treat the un-treatable, recover the unrecoverable, extend the lives of those told to get their affairs in order and become THE center of regenerative medical innovation in the US, if not, the world.

 

……………………………………………..

I now see that there was media coverage; we just apparently beat them all to the punch.  I am more than pleased that this advance is getting mass media coverage!

Stem Cell Therapy Becomes Law in Texas – Hawaii News Now … 2 hours ago – LA JOLLA, Calif., June 13, 2017 /PRNewswire/ — House Bill (HB 810) on stem celltherapy has passed in the Texas state legislature and become law. Patients in …

Health Care – FOX5 Vegas – KVVU  17 mins ago – House Bill (HB 810) on stem cell therapy has passed in the Texas state legislature and become law. Patients in Texas will now have access to this “Right to Try” …

Health Care – WDRB 41 Louisville News  36 mins ago – House Bill (HB 810) on stem cell therapy has passed in the Texas state legislature and become law. Patients in Texas will now have access to this “Right to Try” …

Stem Cell Therapy Becomes Law in Texas – WorldNews  3 hours ago – LA JOLLA, Calif., June 13, 2017 /PRNewswire/ — House Bill (HB 810) on stem celltherapy has passed in the Texas state legislature and become law. Patients in …

– TiGenix Launches Global Phase III Trial for Cx601 (EN – NL – ES …45 mins ago – LA JOLLA, Calif., June 13, 2017 /PRNewswire/ — House Bill (HB 810) on stem celltherapy has passed in the Texas state legislature and become law. Patients in …

TiGenix announces final equity payment for cardiac platform …  41 mins ago – LA JOLLA, Calif., June 13, 2017 /PRNewswire/ — House Bill (HB 810) on stem celltherapy has passed in the Texas state legislature and become law. Patients in …

Hope for Gabe Foundation Races Across America to Bring Awareness …   50 mins ago – LA JOLLA, Calif., June 13, 2017 /PRNewswire/ — House Bill (HB 810) on stem celltherapy has passed in the Texas state legislature and become law. Patients in …

 

<a href=”http://www.notey.com/blog/137053#blog/e0d53ff314e0f9a74de67a2965c2ba78″></a&gt;

Advertisements

Anecdotal – The Dirty Word in Gordie Howe’s Stem Cell Treatment

In ALL ARTICLES on February 10, 2015 at 7:35 pm

What does it tell you when expert after expert tries to discredit the results of Gordie Howe’s stem cell treatment while his son Dr. Murray Howe, chairman of Toledo Hospital’s department of radiology, credits the stem cells for his recovery?

Dr. Murray Howe is the chairman of Toledo Hospital's department of radiology.

Dr. Murray Howe is the chairman of Toledo Hospital’s department of radiology.

What does it tell you when expert after expert claim his recovery and improvements are insignificant…while simultaneously attributing his recovery and improvements to everything except the stem cells he received?

What does it tell you when expert after expert discredits the anecdotal evidence of Gordie Howe’s recovery as “merely anecdotal” while it is actually one mere drop in an ocean of tens of thousands per year who have improved from cancer with cellular therapies over the last 59 years and tens of thousands who have improved over the past 12-14 years from non-cancer conditions?

And what is the value of this huge array of empirical and anecdotal evidence?

Gordie Howe Recovers From Stroke with Stem Cells

Gordie Howe Recovers From Stroke with Stem Cells

There are many types of evidence, not just trials or anecdotal.  Too often we reduce the evidential options to either clinical trials or anecdote.  Wrong.  That’s 5 blind men describing an elephant all over again.  We must take into account ALL of the different types of evidence and only THEN we can make a judgment based on the cumulative evidential data.

Anecdotal Evidence – Peyton Manning, Kobe Bryant, Rafael Nadar, Bartolo Colon…athletes from major sports organizations all over the world are embracing and anecdotally illustrating the safety and efficacy of cellular therapies

Statistical Evidence – 50,000 patients per year… are statistically illustrating the safety and efficacy of cellular therapies

Testimonial Evidence – Youtube is chock full of testimonies of athletes and patients who are benefiting from cellular therapies and via testimonial, illustrating the safety and efficacy of cellular therapies

Analogical Evidence – 59 years and thousands of trials and studies are analogously illustrating the safety and efficacy of cellular therapies

Clinical Trial evidence – Even though it may be the wrong process to evaluate cellular therapies, the vast majority of over 2,400 clinical trials are scientifically and empirically illustrating the safety and efficacy of cellular therapies

Miracle results? No.  This is par for the course results from real expectations based on the multitude of evidence types collected over the past six decades for cellular therapies.  The combined patchwork of all of the data from all of these evidences paints a very compelling conclusion.

Are cellular therapies safe and effective?  All of the evidences seem to say so.  Not just the anecdotal evidence;
anecdotal,
statistical,
testimonial,
analogical
and clinical trial evidences.

by David Granovsky, Stem Cell Writer and Author

Read one of the many myopically evidential articles here: http://www.theglobeandmail.com/globe-debate/the-stem-cell-miracle-is-anecdotal/article22880977/

Two More Patients HIV-Free After Bone Marrow Transplants – ABC News

In VICTORIES & SUCCESS STORIES on September 12, 2012 at 5:08 pm

Read the story on the first man to recover from HIV Positive with a stem cell transplant who is now symptom free for 5 years! https://repairstemcell.wordpress.com/2010/12/10/man-appears-free-of-hiv-after-stem-cell-transplant-for-3-years/

And with these 2 more men now HIV free, perhaps the dream of an HIV Free Generation is one step closer to reality!

Two More Patients HIV-Free After Bone Marrow Transplants

Researchers at Brigham and Women’s Hospital in Boston have discovered that, following bone marrow transplants, two men no longer have detectable HIV in their blood cells.

The finding is significant because it suggests that by giving these patients transplants while they were on anti-retroviral therapy, they may have been cured of the AIDS-causing virus.

“We expected HIV to vanish from the patients’ plasma, but it is surprising that we can’t find any traces of HIV in their cells,” said Dr. Timothy Henrich, one of the researchers studying the two men. “It suggests that under the cover of anti-retroviral therapy, the cells that repopulated the patient’s immune system appear to be protected from becoming re-infected with HIV.”…


Two More Patients HIV-Free After Bone Marrow Transplants – ABC News
.

CEREBRAL PALSY AND STEM CELLS

In STEM CELLS IN THE NEWS on April 10, 2012 at 10:24 am

https://repairstemcell.wordpress.com/2011/02/22/little-lucass-stem-cell-hope/
https://repairstemcell.wordpress.com/2010/08/28/cord-blood-wakes-up-drowning-victim%e2%80%99s-brain/

https://repairstemcell.wordpress.com/2010/07/12/shiu-sisters-cp-and-rop-adult-stem-cell-patients/

Duke U. CLINICAL TRIAL for Cerebral Palsy & other newborn brain injuries – http://www.clinicaltrials.gov/ct2/show/NCT00593242?term=hypoxic+ischemic+encephalopathy&rank=3 – for more information – http://parentsguidecordblood.org/content/usa/medical/autocbt.shtml or for anecdotal info – Abby , Chloe, Dallas

Dallas Hextell, a 2-year-old from Sacramento, California, received an infusion of his own umbilical cord blood as part of the Duke University clinical trial. Within five days, he showed improvements in the limitations imposed by the condition.  video: http://www.msnbc.msn.com/id/21134540/vp/23569985#23569985
via http://www.youhavealawyer.com/blog/2008/03/26/cerebral-palsy-improvement/

“a toddler with cerebral palsy, who experienced dramatic improvements in his disability following an experimental procedure involving a stem cell transplant.” – http://pediatrics.duke.edu/modules/dept_peds_annc/index.php?id=79\

Cerebral Palsy: Cord Blood Stem Cell Research and Treatment in Clinical Trials – Update

Thursday, April 29th, 2010

For those of  you who follow our blogs, you know well that this is a topic of interest for us.  It bears repeating – our job as lawyers is to properly investigate potential claims of malpractice in areas such as cerebral palsy and seek redress for our clients when the evidence demonstrates a connection between birth injuries and medical care, but the much more important topic for our clients and victims of cerebral palsy is in the field of medical research. It is through research efforts – including clinical trials – that this dreaded condition will be ameliorated and hopefully eradicated. Trust me, after practicing law for over 35 years, I’m not worried about job security – the frailties of the human condition will more than suffice to fill our file cabinets with people to help due to the negligence of others.

We have reported previously on various topics involving cord blood and stem cell research as they relate to a number of conditions, including cerebral palsy.  It seems that months have passed since there has been any significant news about two programs underway: one at the Medical College of Georgia and the other at Duke.  Earlier this month, an update came across the social media network via a post by Singularity Hub – Cord Blood Stem Cell Treatment for Cerebral Palsy in Clinical Trial | Singularity Hub.

Here’s our encapsulated version regarding the studies and Singularity Hub’s report.

Photo provided by MSNBC

Duke University

According to the website ClincalTrials.gov, Duke began a clinical therapeutic trial – identifier: NCT00593242 – in January 2008 (estimated completion date of January 2011) whose primary purpose is listed as treatment of newborns with hypoxic ischemic encephalopathy (HIE) – inadequate oxygenation in the perinatal period for purposes of this study – through the controlled “collection, preparation and infusion of a baby’s own (autologous) umbilical cord blood in the first 14 days after birth if the baby is born with signs of brain injury.” For information concerning the inclusion and exclusion criteria for participation in this clinical trial, see the online posting. Essentially, the babies are then to be “followed for neurodevelopmental outcome at 4 – 6 and 9 – 12 months at Duke’s Special Infant Care Clinic. MRI’s will be obtained between postnatal weeks 1 and 4, and, for study purposes at 4 – 6 postnatal months.”

While other aspects of processing and administration are no doubt part of the key components of this project, it is readily apparent that the end-point goal is discovery of an effective treatment of cerebral palsy for the identified neonates in the study and then development of a second stage clinical trial to take such treatment modality to a greater number of potential beneficiaries.

Medical College of Georgia

For detailed information on this study, which began in February of this year, similar information is available through ClinicalTrials.gov under identifier NCT01072370.  This clinical trial investigation has a patient population consisting of children from ages of 2 to 12, “whose parents have saved their infant’s cord blood, who have non-progressive motor disability, and whose parents intend to have a cord blood infusion.”  Again – for full details regarding inclusion and exclusion criteria, see the full online posting.

For those parents who may be interested in determining if their child would qualify to participate, the study is still recruiting participants.  The contact information is also available at this link: Contact: James E Carroll, M.D.     706-721-3371     jcarroll@mcg.edu

Today’s report from Singularity Hub provides some encouraging – albeit anecdotal – news of potential progress.

The anecdotal evidence in support of treating cerebral palsy with cord blood stem cells is astounding. Much of it has actually been been performed at Duke University by one of the investigators in the pilot study: Joanne Kurtzberg. Among those that have been successfully treated at Duke include Ryan Schneider, Maia Friedlander, Chloe Levine, and Dallas Hextell. All had CP or CP-like symptoms and all made remarkable recoveries after cord blood stem cell treatments. Dallas Hextell, who showed improvements just 5 days after his therapy was featured on the Today show (the original report contains video compliments of MSNBC).

In addition to the early good news coming out of these projects, one other lesson is learned – for the time being, the storage of cord blood is an important component for those hoping to participate in such studies – particularly that being conducted at the Medical College of Georgia.  We have earlier reported on this topic as well.  You may want to refer to our early posting for some basic information if you are interested.

Obviously, the implications – if these projects prove to be successful – are far-reaching. The enthusiasm of the participants in these research projects is not limited to them alone. The words of the author, Aaron Saenz, from Singularity Hub somewhat tells it all:

So we have some exciting news for cerebral palsy, and some exciting news for those thinking about cord blood. What about the rest of us? Well the MCG and Duke work has some far reaching implications. Neurological damage, whether it’s caused by oxygen deprivation or some other injury, is one of the most difficult things to heal in the body. Work in animals (like that done by Carroll on rats) show that stem cells can not only help damaged brain cells recover, but they can also replace cells that have died. We may find that stem cells therapies have a wide range of applications for many different forms of brain damage. Kurtzberg is researching many different ways cord blood could be used (autologous or through donors) to treat a variety of conditions. In other words, today stem cells conquer cerebral palsy…tomorrow, the world.

Let’s all hope that Mr. Saenz is a prophet.

 

https://repairstemcell.wordpress.com/2010/10/24/the-challenging-life-of-a-young-man-with-cp-neil-barron/

CellNEWS: Scientists Learn How Stem Cell Implants Help Heal Traumatic Brain Injury

In VICTORIES & SUCCESS STORIES on January 22, 2012 at 9:20 am

“In this study, we found that our stem cell transplantation both prevents further axonal injury and promotes axonal regrowth, through a number of previously unknown molecular mechanisms.”

https://i0.wp.com/trialx.com/curetalk/wp-content/blogs.dir/7/files/2011/06/Tramautic_Brain_Injury.jpg

Scientists Learn How Stem Cell Implants Help Heal Traumatic Brain Injury  
Friday, 13 January 2012

For years, researchers seeking new therapies for traumatic brain injury have been tantalized by the results of animal experiments with stem cells. In numerous studies, stem cell implantation has substantially improved brain function in experimental animals with brain trauma. But just how these improvements occur has remained a mystery.

Now, an important part of this puzzle has been pieced together by researchers at the University of Texas Medical Branch at Galveston. In experiments with both laboratory rats and an apparatus that enabled them to simulate the impact of trauma on human neurons, they identified key molecular mechanisms by which implanted human neural stem cells — stem cells that are in the process of developing into neurons but have not yet taken their final form — aid recovery from traumatic axonal injury.
A significant component of traumatic brain injury, traumatic axonal injury involves damage to axons and dendrites, the filaments that extend out from the bodies of the neurons. The damage continues after the initial trauma, since the axons and dendrites respond to injury by withdrawing back to the bodies of the neurons.
“Axons and dendrites are the basis of neuron-to-neuron communication, and when they are lost, neuron function is lost,” said UTMB professor Ping Wu, lead author of a paper on the research appearing in the Journal of Neurotrauma.

“In this study, we found that our stem cell transplantation both prevents further axonal injury and promotes axonal regrowth, through a number of previously unknown molecular mechanisms.”

 

Read more: CellNEWS: Scientists Learn How Stem Cell Implants Help Heal Traumatic Brain Injury.

HEARTS and KNEES – Patient, heal thyself | sciencebuz

In VICTORIES & SUCCESS STORIES on January 21, 2012 at 9:20 am

“The first study…uses stem cell therapy to repair heart tissue damaged by coronary heart disease. Of the 16 patients injected with autologous CSCs, 14 showed an increase in Left Ventricular Ejection Fraction (LVEF)…In seven of the patients, infarct (dead tissue) size decreased by 24 % at the end of 4 months, and a further 6 % at the end of a year. Both these results indicate CSCs had a positive impact on heart tissue regeneration.

The second study…focuses on using autologous stem cell therapy for repair of torn meniscal tissue…The “Cell Bandage” from Azellon will use patients own, expanded stem cells, harvested from the bone marrow…will grow into new menisci-type cells and heal the tear. The results of in vitro trials have so far been very promising. Phase I clinical trials are set to begin May 2012.”

https://i2.wp.com/www.designmom.com/wp-content/uploads/2011/02/5417124292_6a49ef3983.jpg

Two reports in the press this week focus on the use of autologous (patient’s own) stem cells for repair of damaged tissue.

The first study, led by Professor Roberto Bolli, of the University of Louisville, reports on early findings of a phase I clinical trial, which uses stem cell therapy to repair heart tissue damaged by coronary heart disease. Cardiac tissue, harvested from the patient during surgery, was used to  isolate autologous cardiac stem cells (CSCs). CSCs were grown in the laboratory till their numbers reached around 2 million cells. At this stage the cells were re-injected back at the site of tissue damage.

Of the 16 patients injected with autologous CSCs, 14 showed an increase in Left Ventricular Ejection Fraction (LVEF) – the amount of blood a left ventricle pumps through the aorta during each contraction of the heart, 4 months after infusion. In seven of the patients, infarct (dead tissue) size decreased by 24 % at the end of 4 months, and a further 6 % at the end of a year. Both these results indicate CSCs had a positive impact on heart tissue regeneration.

The second study, led by Professor Anthony Hollander, of Azellon Ltd, a University of Bristol spin-out company, focuses on using autologous stem cell therapy for repair of torn meniscal tissue. The menisci are found at the knee joints, and they act as shock absorbers for the knee. This tissue is often damaged as a result of sport-related injury, especially contact sports such as football or rugby.

Current treatment options include knee arthroscopy surgery, which involves removing part or whole of the damaged meniscal tissue. This reduces the shock-absorbing properties at the knee joint and leaves the patient vulnerable to early-onset osteoarthritis, eventually followed by total knee replacement.

The “Cell Bandage” from Azellon will use patients own, expanded stem cells, harvested from the bone marrow. These cells are seeded onto a special biocompatible membrane, which will be inserted at the site of damage using a simple surgical procedure.  Given the right conditions, the hope is that stem cells will grow into new menisci-type cells and heal the tear. The results of in vitro trials have so far been very promising. Phase I clinical trials are set to begin May 2012.

Patient, heal thyself | sciencebuz.

CellNEWS: Bone Marrow-derived Cells Differentiate in the Brain through Mechanisms of Plasticity

In VICTORIES & SUCCESS STORIES on January 20, 2012 at 9:19 am

“This study shows a potential new contribution of bone marrow derived cells following transplantation into the brain, making these cells highly versatile, in their ability to both differentiate into and fuse with endogenous neurons

Bone Marrow-derived Cells Differentiate in the Brain through Mechanisms of Plasticity
Monday, 19 December 2011

Bone marrow-derived stem cells (BMDCs) have been recognized as a source for transplantation because they can contribute to different cell populations in a variety of organs under both normal and pathological conditions. Many BMDC studies have been aimed at repairing damaged brain tissue or helping to restore lost neural function, with much research focused on BMDC transplants to the cerebellum at the back of the brain. In a recent study, a research team from Spain has found that BMDCs, can contribute to a variety of neural cell types in other areas of the brain as well, including the olfactory bulb, because of a mechanism of “plasticity”.
Their results are published in the current issue of Cell Transplantation (20:8).
“To our knowledge, ours is the first work reporting the BMDC’s contribution to the olfactory neurons,” said study corresponding author Dr. Eduardo Weruaga of the University of Salamanca, Spain.
“We have shown for the first time how BMDCs contribute to the central nervous system in different ways in the same animal depending on the region and cell-specific factors.”
In this study, researchers grafted bone marrow cells into mutant mice suffering from the degeneration of specific neuronal populations at different ages, then compared them to similarly transplanted healthy controls. An increase in the number of BMDCs was found along the lifespan in both experimental groups. Six weeks after transplantation, however, more bone marrow-derived microglial cells were observed in the olfactory bulbs of the test animals where the degeneration of mitral cells was still in progress. The difference was not observed in the cerebellum where cell degeneration had been completed.
“Our findings demonstrate that the degree of neurodegenerative environment can foster the recruitment of neural elements derived from bone marrow,” explained Dr. Weruaga.
“But we also have provided the first evidence that BMDCs can contribute simultaneously to different encephalic areas through different mechanisms of plasticity – cell fusion for Purkinje cells – among the largest and most elaborately dendritic neurons in the human brain – and differentiation for olfactory bulb interneurons.”
Dr. Weruaga noted that they confirmed that BMDCs fuse with Purkinje cells but, unexpectedly, they found that the neurodegenerative environment had no effect on the behavior of the BMDCs.
“Interestingly, the contribution of BMDCs occurred through these two different plasticity mechanisms, which strongly suggests that plasticity mechanisms may be modulated by region and cell type-specific factors,” he said.
“This study shows a potential new contribution of bone marrow derived cells following transplantation into the brain, making these cells highly versatile, in their ability to both differentiate into and fuse with endogenous neurons” said Dr. Paul R. Sanberg , coeditor-in-chief of Cell Transplantation and distinguished professor of Neuroscience at the Center of Excellence for Aging and Brain Repair, University of South Florida.
Source: Cell Transplantation Center of Excellence for Aging and Brain Repair

Contact: David Eve

Reference:

Bone Marrow Contributes Simultaneously to Different Neural Types in the Central Nervous System Through Different Mechanisms of Plasticity
Recio, J. S.; Álvarez-Dolado, M.; Díaz, D.; Baltanás, F. C.; Piquer-Gil, M.; Alonso, J. R.; Werunga, E.
Cell Transplant. 20(8):1179-1192; 2011

CellNEWS: Bone Marrow-derived Cells Differentiate in the Brain through Mechanisms of Plasticity.

ALS adult stem cell trial = safe and effective | Reuters

In VICTORIES & SUCCESS STORIES on January 19, 2012 at 9:28 am

(Reuters) – Data from the first ALS patients in a clinical trial treated with BrainStorm Cell Therapeutics adult stem cell therapy did not show significant side effects and the treatment has so far proven to be safe, the company said on Tuesday.

Israel-based BrainStorm is developing NurOwn for the treatment of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s Disease, a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.

The U.S. Food and Drug Administration last year granted orphan drug designation to NurOwn. The FDA’s orphan drug program encourages the development of treatments for rare diseases by providing financial incentives.

“There have been no significant side effects in the initial patients we have treated with BrainStorm’s NurOwn technology,” said Dimitrios Karussis, the head of Israel’s Hadassah Medical Center’s Multiple Sclerosis unit, who is leading the clinical trial.

“In addition, even though we are conducting a safety trial, the early clinical follow-up of the patients treated with the stem cells shows indications of beneficial clinical effects, such as an improvement in breathing and swallowing ability as well as in muscular power.”

Patients in the trial are transplanted with stem cells derived from their own bone marrow and treated with the NurOwn stem cell technology.

The initial phase of the study is designed to establish the safety of NurOwn and will later be expanded to assess efficacy.

“Based on the interim safety report, the hospital ethical and safety committee granted the company approval to proceed with treating the next patients,” said Chaim Lebovits, president of BrainStorm.

According to the ALS Association, 5,600 people in the United States are diagnosed with the disease each year. It is estimated that as many as 30,000 Americans may have the disease — which has severely disabled British physicist Stephen Hawking — at any given time.

BrainStorm sees positive data in ALS stem cell trial | Reuters.

Stem Cell Transplant Helps Hawaii Professor Live

In VICTORIES & SUCCESS STORIES on January 19, 2012 at 9:14 am

ADULT Stem Cell Transplant Helps Hawaii Professor Live

kessler stem cell

University of Hawaii associate professor, Cristy Kessler, was suffering from a rare combination of three different autoimmune diseases:

  1. Vasculitis,
  2. Scleroderma,
  3. Akylosing Spondyliitis.

The pain was so bad, that, in her own words, she was “preparing to die.” She was constantly on a combination of prescription pain medications including morphine and vicadin, and could barely walk down the street.

Stem cell transplant looked like the only viable option for Cristy, but because the procedure is not approved by the FDA or covered by insurance, she would have to look overseas for options.

Because her disease was still in the early phase, doctors were optimistic about her prognosis. In March 2010, Dr. Zafer Gulbas led the taxing two month long procedure consisting of chemotherapy, frequent blood tests, and isolation.

Although long term results won’t be measured for some time, the stem cell transplant seems to have been a success. Kessler is now off the prescription pain medications that she previously depended on just to function, and has a new life. Her immune system is fragile and she is dependent on antibiotics, but says she now wants to enjoy music and “dance like a fool” without being in pain. Watch the video from KITV Honolulu

Stem Cell Transplant Helps Hawaii Professor Live.

THANK YOU TO ALL MY READERS!!!

In ALL ARTICLES on October 22, 2011 at 12:07 am

Just a quick note of thanks to all of my readers!

The US may be ignorant of the benefits of adult stem cells but you are not!

  • 1,531,611 views all-time
  • 6,955 views on busiest day

Here’s to our next 1.5 million and all the people we can help together!

Good luck and good health!

David

We’ve come a long way baby!

%d bloggers like this: